CITADEL ADVISORS LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
CITADEL ADVISORS LLC | 1,236,850 2.400% |
-1,022,891 (-45.27%) |
Filing |
| 2023-05-19 4:05 pm Purchase |
2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP |
CITADEL ADVISORS LLC | 2,259,741 4.900% |
875,242 (+63.22%) |
Filing |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
CITADEL ADVISORS LLC | 1,384,499 3.000% |
-1,025,343 (-42.55%) |
Filing |
| 2022-06-17 4:02 pm Purchase |
2022-06-07 | 13G | PMV Pharmaceuticals, Inc. PMVP |
CITADEL ADVISORS LLC | 2,409,842 5.300% |
2,409,842 (New Position) |
Filing |